1
|
Hermans R, Kloosterboer S, Sassen S, Reichart C, Kouijzer M, de Kroon M, van Daalen E, Rieken R, van Schaik R, Nasserinejad K, Hillegers M, de Winter B, Koch B, Dierckx B. Linking pharmacokinetics of aripiprazole to side effects and
effectiveness in children and adolescents. PHARMACOPSYCHIATRY 2022. [DOI: 10.1055/s-0042-1747653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- R.A. Hermans
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The
Netherlands
- Department of Child and Adolescent Psychiatry/Psychology,
Erasmus Medical Center, Rotterdam, the Netherlands
- Rotterdam Clinical Pharmacometrics Group, Erasmus Medical Center,
Rotterdam, The Netherlands
| | - S.M. Kloosterboer
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The
Netherlands
- Department of Child and Adolescent Psychiatry/Psychology,
Erasmus Medical Center, Rotterdam, the Netherlands
| | - S.D.T. Sassen
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The
Netherlands
- Rotterdam Clinical Pharmacometrics Group, Erasmus Medical Center,
Rotterdam, The Netherlands
| | - C.G. Reichart
- LUMC-Curium Child and Adolescent Psychiatry, Leiden University Medical
Center, Oegstgeest, The Netherlands
| | | | | | | | - R. Rieken
- GGZ Delfland, Department of Youth, Delft, The Netherlands
| | - R.H.N. van Schaik
- Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam,
The Netherlands
| | - K. Nasserinejad
- Department of Hematology, Erasmus Medical Center, Rotterdam, The
Netherlands
| | - M.H.J. Hillegers
- Department of Child and Adolescent Psychiatry/Psychology,
Erasmus Medical Center, Rotterdam, the Netherlands
| | - B.C.M. de Winter
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The
Netherlands
- Rotterdam Clinical Pharmacometrics Group, Erasmus Medical Center,
Rotterdam, The Netherlands
| | - B.C.P. Koch
- Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The
Netherlands
- Rotterdam Clinical Pharmacometrics Group, Erasmus Medical Center,
Rotterdam, The Netherlands
| | - B. Dierckx
- Department of Child and Adolescent Psychiatry/Psychology,
Erasmus Medical Center, Rotterdam, the Netherlands
| |
Collapse
|
2
|
Zinkstok JR, Velders F, Rieken R, Houben M, Fiksinski A, van Amelsvoort TAMJ, Boot E. [Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome]. Tijdschr Psychiatr 2020; 62:229-233. [PMID: 32207133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The 22q11.2 deletion syndrome (22q11.2ds) is a genetic syndrome affecting multiple organ systems and is associated with increased risk of developing neuropsychiatric disorders. We describe a 15-year old female adolescent with 22q11.2ds, psychotic disorder, and catatonia. Individuals with 22q11.2ds are at increased risk of developing catatonia. Vulnerability for developing extrapyramidal symptoms and epileptic seizures may complicate pharmacological treatment for psychotic episodes. There may be a diagnostic delay of diagnosing Parkinson's disease in patients taking antipsychotics as parkinsonism may be viewed as a side effect. Health professionals working with people with 22q11.2ds should be aware of the increased prevalence of movement disorders and the threshold for referral to 22q11.2ds specialist services should be low.
Collapse
|
3
|
Mergler S, Rieken R, Tibboel D, Evenhuis HM, van Rijn RR, Penning C. Lumbar spine and total-body dual-energy X-ray absorptiometry in children with severe neurological impairment and intellectual disability: a pilot study of artefacts and disrupting factors. Pediatr Radiol 2012; 42:574-83. [PMID: 22252145 PMCID: PMC3337401 DOI: 10.1007/s00247-011-2307-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/11/2011] [Revised: 09/15/2011] [Accepted: 09/17/2011] [Indexed: 11/30/2022]
Abstract
BACKGROUND Children with severe neurological impairment and intellectual disability (ID) are susceptible for developing low bone mineral density (BMD) and fractures. BMD is generally measured with dual-energy X-ray absorptiometry (DXA). OBJECTIVE To describe the occurrence of factors that may influence the feasibility of DXA and the accuracy of DXA outcome in children with severe neurological impairment and ID. MATERIALS AND METHODS Based on literature and expert opinion, a list of disrupting factors was developed. Occurrence of these factors was assessed in 27 children who underwent DXA measurement. RESULTS Disrupting factors that occurred most frequently were movement during measurement (82%), aberrant body composition (67%), small length for age (56%) and scoliosis (37%). The number of disrupting factors per child was mean 5.3 (range 1-8). No correlation was found between DXA outcomes and the number of disrupting factors. CONCLUSION Factors that may negatively influence the accuracy of DXA outcome are frequently present in children with severe neurological impairment and ID. No systematic deviation of DXA outcome in coherence with the amount of disrupting factors was found, but physicians should be aware of the possible influence of disrupting factors on the accuracy of DXA.
Collapse
Affiliation(s)
- S. Mergler
- Intellectual Disability Medicine/Department of General Practice, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
| | - R. Rieken
- Intellectual Disability Medicine/Department of General Practice, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
| | - D. Tibboel
- Department of Pediatric Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - H. M. Evenhuis
- Intellectual Disability Medicine/Department of General Practice, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
| | - R. R. van Rijn
- Department of Radiology, Academic Medical Centre, Amsterdam, The Netherlands
| | - C. Penning
- Intellectual Disability Medicine/Department of General Practice, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
| |
Collapse
|
4
|
Schierbeek H, Rieken R, Dorst KY, Penning C, van Goudoever JB. Validation of deuterium and oxygen18 in urine and saliva samples from children using on-line continuous-flow isotope ratio mass spectrometry. Rapid Commun Mass Spectrom 2009; 23:3549-3554. [PMID: 19844971 DOI: 10.1002/rcm.4279] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The doubly labelled water method is valuable for measuring energy expenditure in humans. It usually involves blood or urine sampling, which might be difficult in neonates and children with cerebral palsy or other disabilities. We therefore aimed to validate a method making use of saliva samples analyzed by automated thermal conversion elemental analyzer in combination with isotope ratio mass spectrometry (TC-EA/IRMS). The subjects received labelled water orally and urine and saliva samples were collected and analyzed. Deuterium as well as oxygen18 was measured in one single run using a peak jump method. Excellent linearity was found for measurement of enrichments of deuterium (R2 = 0.9999) and oxygen18 (R2 = 0.9999). The intra-assay precision and the inter-assay precision of the measurement of two standards were good for both deuterium and oxygen18. The variation between urine and saliva samples was small (4.83% for deuterium and 2.33% for oxygen18 n = 40). Saliva sampling is to be preferred, therefore, as it can be easily collected and is non-invasive. Moreover, its time of production is almost exactly known. The TC-EA/IRMS method is a good alternative to the more laborious off-line IRMS measurements.
Collapse
Affiliation(s)
- H Schierbeek
- Erasmus Medical Center-Sophia Children's Hospital, Department of Paediatrics, Division of Neonatology, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
| | | | | | | | | |
Collapse
|